ANTIPHOSPHOLIPID ANTIBODY APLA PANEL Test
Test Cost: AED 1050.0
Components
- B177 – BETA 2 GLYCOPROTEIN 1, IgG
- B178 – BETA 2 GLYCOPROTEIN 1, IgM
- S054 – CARDIOLIPIN ANTIBODY IgM
- S055 – CARDIOLIPIN ANTIBODY IgG
- H123 – LUPUS ANTICOAGULANT BY dRVVT
Sample Condition
2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.
3 mL whole blood in 1 Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion. Transport to Lab within 4 hours. If this is not possible, make PPP within 1 hour of collection as follows: Centrifuge sample at 3600 rpm for 15 min. & transfer supernatant to a clean plastic tube. Centrifuge this supernatant again at 3600 rpm for 15 min. & finally transfer the supernatant (PPP) to 1 labelled clean plastic screw capped vial. FREEZE IMMEDIATELY. Ship frozen. DO NOT THAW. Overnight fasting is preferred. Duly filled Coagulation Requisition Form(Form 15) is mandatory.
Report Delivery
SampleMon / Thu by 9 am; Report Next day
Method
Electromechanical Clot Detection, Enzyme Immunoassay
Test Type
Autoimmune Disorders
Doctor
Gynecologist
Test Department
IMMUNOPATHOLOGY
Pre Test Information
Overnight fasting is preferred.
Test Details
The antiphospholipid antibody (APLA) panel test is a blood test used to diagnose antiphospholipid syndrome (APS). APS is an autoimmune disorder in which the immune system mistakenly produces antibodies that attack phospholipids, a type of fat found in cell membranes. This can lead to blood clot formation and other complications.
The APLA panel test measures the levels of different types of antibodies in the blood, including anticardiolipin antibodies (aCL), lupus anticoagulant (LA), and anti-beta2-glycoprotein I antibodies (anti-2GPI). These antibodies are commonly found in individuals with APS.
The test is typically ordered if a person has experienced blood clots in unusual locations, recurrent miscarriages, or other symptoms suggestive of APS. It can also be used to monitor the effectiveness of treatment in individuals with APS.
The APLA panel test is usually performed on a blood sample. The blood is drawn from a vein in the arm and sent to a laboratory for analysis. Results are typically reported as positive or negative for each type of antibody.
A positive result on the APLA panel test indicates the presence of antiphospholipid antibodies and suggests a diagnosis of APS. However, a positive result does not necessarily mean that a person has APS, as these antibodies can also be found in other autoimmune disorders or as a result of certain medications. Therefore, a positive result should be interpreted in the context of the individual’s clinical history and other test results.
It is important to note that the APLA panel test should be interpreted by a healthcare professional with expertise in autoimmune disorders.
Treatment for APS may involve blood thinners or other medications to prevent blood clots and manage symptoms.
| Test Name | ANTIPHOSPHOLIPID ANTIBODY APLA PANEL Test |
|---|---|
| Components | *B177* BETA 2 GLYCOPROTEIN 1, IgG *B178* BETA 2 GLYCOPROTEIN 1, IgM *S054* CARDIOLIPINANTIBODYIgM *S055* CARDIOLIPINANTIBODYIgG *H123* LUPUS ANTICOAGULANT BY dRVVT |
| Price | 1050.0 AED |
| Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen&\n3 mL whole blood in 1 Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion. Transport to Lab within 4 hours. If this is not possible, make PPP within 1 hour of collection as follows: Centrifuge sample at 3600 rpm for 15 min. & transfer supernatant to a clean plastic tube. Centrifuge this supernatant again at 3600 rpm for 15 min. & finally transfer the supernatant (PPP) to 1 labelled clean plastic screw capped vial. FREEZE IMMEDIATELY. Ship frozen. DO NOT THAW. Overnight fasting is preferred. Duly filled Coagulation Requisition Form(Form 15) is mandatory. |
| Report Delivery | SampleMon / Thu by 9 am; Report Next day |
| Method | Electromechanical Clot Detection, Enzyme Immunoassay |
| Test type | Autoimmune Disorders |
| Doctor | Gynecologist |
| Test Department: | IMMUNOPATHOLOGY |
| Pre Test Information | Overnight fasting is preferred. |
| Test Details | The antiphospholipid antibody (APLA) panel test is a blood test used to diagnose antiphospholipid syndrome (APS). APS is an autoimmune disorder in which the immune system mistakenly produces antibodies that attack phospholipids, a type of fat found in cell membranes. This can lead to blood clot formation and other complications. The APLA panel test measures the levels of different types of antibodies in the blood, including anticardiolipin antibodies (aCL), lupus anticoagulant (LA), and anti-beta2-glycoprotein I antibodies (anti-2GPI). These antibodies are commonly found in individuals with APS. The test is typically ordered if a person has experienced blood clots in unusual locations, recurrent miscarriages, or other symptoms suggestive of APS. It can also be used to monitor the effectiveness of treatment in individuals with APS. The APLA panel test is usually performed on a blood sample. The blood is drawn from a vein in the arm and sent to a laboratory for analysis. Results are typically reported as positive or negative for each type of antibody. A positive result on the APLA panel test indicates the presence of antiphospholipid antibodies and suggests a diagnosis of APS. However, a positive result does not necessarily mean that a person has APS, as these antibodies can also be found in other autoimmune disorders or as a result of certain medications. Therefore, a positive result should be interpreted in the context of the individual’s clinical history and other test results. It is important to note that the APLA panel test should be interpreted by a healthcare professional with expertise in autoimmune disorders. Treatment for APS may involve blood thinners or other medications to prevent blood clots and manage symptoms. |
